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Summary				The	objective	of	this	study	was	to	establish	the	use	of	an	acoustic	ECG	monitor	(Audicor)	in	healthy	horses.	It	provides	noninvasive,	examiner-independent,	continuous	analysis	combining	ECG	and	phonocardiography	to	calculate	indices	of	cardiac	mechanical	activity	and	haemodynamics.	Device	usability	was	investigated,	reference	intervals	calculated	and	reproducibility	of	analyses	assessed.	Methods:	Continuous	overnight	recordings	were	obtained	in	123	healthy	horses.	Electromechanical	activating	time	(EMAT),	rate-corrected	EMATc,	left	ventricular	systolic	time	(LVST),	rate-corrected	LVSTc	and	intensity	and	persistence	of	the	third	and	fourth	heart	sound	(S3,	S4)	were	reported.	Associations	with	age	and	reproducibility	of	analyses	were	assessed.	Results:	Audicor	recordings	of	diagnostic	quality	were	obtained,	with	an	artefact-free	recording	time	of	1:08–14:03h.	44.8%	of	the	horses	had	atrial	premature	complexes.	4.3%	had	ventricular	premature	complexes.	Reference	intervals	were	reported.	S3	was	significantly	more	often	graded	≥5	(scale	0–10)	in	younger	compared	to	older	horses.	The	between-day	coefficient	of	variation	ranged	from	2.5	to	7.7%	for	EMAT,	EMATc,	LVST	and	LVSTc.	Conclusions:	Overnight	Audicor	recordings	are	feasible	in	horses.	Combining	ambulatory	ECG	and	phonocardiography	allows	noninvasive,	continuous	assessment	of	variables	representing	systolic	and	diastolic	cardiac	function.		
Keywords:	horse;	electrocardiogram;	phonocardiogram;	heart	sounds;	cardiovascular		
Zusammenfassung				Ziel	der	Studie	war	es,	die	Anwendung	des	Audicor	Gerätes	durch	Bestimmung	von	Referenzwerten	und	Ermitteln	der	Reproduzierbarkeit	im	klinischen	Alltag	zu	etablieren.	Das	Audicor	Gerät	vereint	kontinuierliches	EKG	und	Phonokardiogramm,	ist	nicht-invasiv	und	Untersucher-unabhängig.	Aussagen	über	die	mechanische	und	hämodynamische	Aktivität	des	Herzens	werden	so	ermöglicht.	Methode:	An	123	gesunden	Pferden	wurden	Aufnahmen	über	Nacht	angefertigt.	Die	festgehaltenen	Variablen	waren	u.a.	elektromechanische	Aktivierungszeit	(EMAT),	Frequenz-korrigierte	EMATc,	linksventrikuläre	Systolenzeit	(LVST),	Frequenz-korrigierte	LVSTc,	Intensität	und	Persistenz	des	3.	und	4.	Herztones	(S3,	S4).	Die	Altersabhängigkeit	und	die	Reproduzierbarkeit	der	Variablen	wurden	untersucht.	Resultate:	Aufnahmen	mit	artefaktfreier	Zeit	von	1:08–14:03h	wurden	angefertigt.	44.8%	der	Pferde	zeigten	supraventrikuläre	Extrasystolen,	4.3%	zeigten	ventrikuläre	Extrasystolen.	Referenzintervalle	für	alle	Variablen	wurden	berechnet.	Bei	jungen	Pferden	wurden	signifikant	mehr	S3	≥5	(Skala	0-10)	registriert.	Der	Variationskoeffizient	für	Aufnahmen	an	verschiedenen	Tagen	variierte	zwischen	2.5	und	7.7%	für	EMAT,	EMATc,	LVST	und	LVSTc.		Fazit:	Aufnahmen	mit	Audicor	beim	Pferd	sind	nicht-invasiv	durchführbar	und	erlauben	kontinuierliche	Aussagen	über	die	systolische	und	diastolische	Herzfunktion.		
Schlüsselwörter:	Pferd;	Elektrokardiogramm;	Phonokardiogramm;	Herztöne;	Kardiovaskulär.		
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Summary
Background: Assessment of cardiac electromechanical function in horses requires training, experience and specialised equipment and does not allow
continuous monitoring over time.
Objectives: The objective of this study was to establish the use of an acoustic ECG monitor (Audicor!) in healthy horses. It provides noninvasive,
examiner-independent, continuous analyses combining ECG and phonocardiography to calculate indices of cardiac mechanical activity and
haemodynamics. Device usability was investigated, reference intervals calculated and reproducibility of analyses assessed.
Study design: Prospective descriptive study.
Methods: Continuous overnight recordings were obtained in 123 healthy horses. ECG and acoustic cardiography analyses were performed.
Electromechanical activating time (EMAT), rate-corrected EMATc, left ventricular systolic time (LVST), rate-corrected LVSTc and intensity and persistence
of the third and fourth heart sound (S3, S4) were reported. Associations with age and reproducibility of analyses were assessed.
Results: Audicor! recordings of diagnostic quality were obtained in 116 horses, with an artefact-free recording time of 1:08–14:03 h (mean 10:21 h).
44.8% of the horses had atrial premature complexes (up to 0.18% of analysed beats), 4.3% had ventricular premature complexes (up to 0.021% of
analysed beats). Reference intervals for acoustic cardiography variables were reported. S3 was significantly more often graded ≥5 (scale 0–10) in
younger compared to older horses (P = 0.0036, R2 = 0.072). The between-day coefficient of variation ranged from 2.5 to 7.7% for EMAT, EMATc, LVST
and LVSTc.
Main limitations: Audicor! algorithms are based on human databases. Horses were deemed clinically healthy without advanced diagnostics. Some
data were lost because of technical difficulties, artefacts and noises.
Conclusions: Overnight Audicor! recordings are feasible in horses. Combining ambulatory ECG and phonocardiography allows noninvasive,
continuous assessment of variables representing systolic and diastolic cardiac function. ECG rhythm analyses require over-reading by a specialist, but
acoustic cardiography variables are based on automated algorithms independent of examiner input. Further studies are required to establish the clinical
value of acoustic cardiography in horses.
Keywords: horse; electrocardiogram; phonocardiogram; heart sounds; cardiovascular
Introduction
Horses are flight animals and high-level athletes that depend on an
efficient and powerful cardiovascular system to manage the physical
requirements of stress and rapid locomotion. Heart diseases are common
in horses and – if severe enough – lead to exercise intolerance and poor
performance [1]. Cardiovascular disease accounts for 5.1% of deaths in
15–23 years old horses and for 8.5% of deaths in horses older than
24 years [2]. The most common cardiac diseases include mitral and aortic
insufficiency [2–5], ventricular septal defects [5,6] and arrhythmias such as
atrial fibrillation [5,7,8]. Because progression of disease into heart failure is
relatively rare and heart failure is only diagnosed when overt clinical signs
of exercise intolerance and congestion develop, its real prevalence is
largely unknown [5].
A variety of different diagnostic methods are routinely available to
assess the cardiovascular system in horses. In field practice, these
primarily include physical examination, careful cardiac auscultation,
exercise testing and laboratory examination. Specialised clinicians and
larger referral centres also offer resting electrocardiography (ECG), stress
ECG, ambulatory Holter ECG and event monitoring, transthoracic
echocardiography, noninvasive blood pressure measurement and cardiac
catheterisation [5]. These more advanced methods require extensive
training and experience and access to the necessary equipment. Hence,
these methods are not readily available in field practice. Diagnostic
findings are often difficult to interpret and are subject to operator error
and intra- and interobserver variability [9–15].
The Audicor! technology represents a noninvasive, ambulatory,
wireless diagnostic point-of-care device that can be applied by any
clinician even in remote field settings. The device has been developed
for use in people with heart disease. It continuously records a single-
lead surface electrocardiogram combined with a phonocardiogram [16].
Using fully automated ECG signal and heart sound analyses, focusing
on systolic time intervals and diastolic heart sound quantification, it
provides a comprehensive, continuous assessment of the electrical and
haemodynamic characteristics of the heart of human patients for up to
several days duration [17–21]. In particular, the device is used in
cardiac patients for diagnostic purposes [19,22–25], to monitor and
optimise therapy [26], to predict prognosis of heart disease [20] and
to screen large populations of patients [16]. Among other variables,
Audicor! measures the electromechanical activation time (EMAT) as
the time interval between the onset of the electrocardiographic Q
wave and the first heart sound. Furthermore, it can quantify the
strength of the third heart sound (S3) and provides a compound
variable called systolic dysfunction index (SDI) that includes both EMAT
and strength of S3 (see Fig 1 and Supplementary Item 1). In people,
strong correlations were found between the strength of S3 and left
ventricular (LV) end-diastolic filling pressures and between EMAT and
the maximum rate of systolic LV pressure change (LV dp/dtmax) and
LV ejection fraction, respectively. Consequently, EMAT, S3 and SDI
were shown to be highly specific to diagnose LV dysfunction and
heart failure [16,27].
In a recent study, it was shown that systolic time intervals can be altered
in horses with mitral and aortic insufficiency, but their clinical value could
not be well documented and remains uncertain at this time [28]. Similarly,
S3 can be heard in healthy horses and in horses with heart disease, but
lacking accurate methods for quantification of the strength of S3, its
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diagnostic and prognostic value in horses with heart disease is not well
established [5,29].
We suggest that Audicor! could be useful for diagnosis and staging of
cardiac diseases in horses, providing insights into rhythm disturbances and
haemodynamic abnormalities through simultaneous assessment of the
electrical and mechanical activity of the heart. This could be helpful to
understand the true prevalence of clinically relevant heart disease and
improve medical care of horses.
In a previous pilot study, the Audicor! device has been shown to be
able to record physiologic data of sufficient quality to be analysed and to
derive a variety of cardiovascular variables in horses (N. Zuber,
unpublished data). The aim of this study was to collect acoustic
cardiography data in a larger group of clinically healthy horses to measure
systolic time intervals, to quantify the prevalence and intensity of diastolic
heart sounds, to investigate their age-related changes and to assess
reference intervals and test–retest variability in acoustic cardiography
variables.
Materials and methods
Study design
The study was designed as a prospective observational trial.
Study group
Clinically healthy horses were recruited from horse stables in various
regions of Switzerland. A total of 123 horses (113 Warmbloods, 4
Thoroughbreds, 6 Standardbreds) between 3 and 27 years of age (11 ! 5
[mean ! s.d.]) were included in the study. The group contained 64 mares,
56 geldings and 3 stallions with a height at the withers of 168 ! 6 cm and
a body weight of 546 ! 53 kg. It consisted of pleasure horses and sports
horses used at different levels of showjumping, dressage and 3-day
eventing.
The horses were deemed clinically healthy based on a medical and
performance history and a comprehensive physical examination (including
careful examination of mucous membranes, jugular veins, peripheral
pulses and auscultation of heart and lungs). Horses that suffered from
cardiorespiratory diseases, other medical issues or any painful conditions
were not included in the study. All horses had to stay free of food
supplements or drugs containing adrenergic or anticholinergic agents,
vasodilators, diuretics, ACE inhibitors, cardiac glycosides or antiarrhythmics
for 1 month prior to the recordings. In addition, no analgesics or anti-
inflammatory drugs were allowed 1 week prior to the recording.
Data recordings
Data recordings were obtained by a single operator (NZ) with the Audicor!
Dx Patch devicea (Fig 2a). This 10 cm long, battery-driven device contains
two dry electrodes for recording of the digital surface ECG signal and a
high-fidelity accelerometer for heart sound recordings and for assessment
of body position, physical activity and respiratory effort (body position,
activity levels and respiratory effort were not analysed within the scope of
this study). Internal digital storage capabilities allow for up to 24 h of data
recording at a sampling rate of 500 Hz.
For this study, the Dx Patch device was fixed with a modified
surcingle to the left side of the horses’ thorax (Fig 2b). The device was
positioned between the 5 and 7th intercostal space, in vertical
orientation, with the white part of the device at the level of the
olecranon and the green part (containing the accelerometer) directed
dorsally. Due to variations in body conformation (thorax, withers), the
surcingle could not be placed in a completely standardised fashion.
Furthermore, the position of the sound sensor could not be optimised
for the varying point of maximum intensity of the heart sounds in
individual horses. Nonetheless, this location allowed recording of a
modified base-apex ECG lead and a phonocardiogram of adequate
quality (N. Zuber, unpublished data; see Fig 1).
All recordings were performed in summer and early fall and the length
of the horses’ hair coat varied. Adequate skin contact was ensured using
dry ECG electrodes with a Ag/AgCl coreb providing a stable and low-noise
interface between skin and device. At the beginning of the recordings, the
fur was slightly wetted with water to allow immediate electrical contact.
Once the mounting system was in place, slight sweating occurring
underneath the mounting system resulted in sufficient electrical contact for
the duration of the recordings. Neither clipping nor shaving was required.
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Fig 1: a) Electrocardiogram and phonocardiogram recorded by the Audicor! Dx Patch device, showing a normal sinus rhythm with a second-degree AV block. The timing
of the measurements (onset of QRS complex, S1, S2) is indicated by vertical lines. The two-dimensional representation of the phonocardiogram displays the sound
frequency on the y-axis, whereas the acoustic energy is colour-coded (low-energy signals in blue, intermediate-energy signals in yellow, high-energy signals in red). Note
that isolated fourth heart sounds, such as in second-degree AV block, are neither detected nor quantified by the analysis algorithm. EMAT, Electromechanical activation
time; LVST, Left ventricular systolic time; S1, first heart sound; S2, second heart sound; S3, third heart sound; S4, fourth heart sound. b) three-dimensional illustration of
the phonocardiogram, showing the four heart sounds (S1–S4) characterised by timing, sound frequency and acoustic energy. Note that the 3D phonocardiogram has a
lower temporal resolution and is created by Audicor! for illustration only.
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After instrumentation, the device was connected via a proprietary Wi-Fi-
type low-power wireless connection to a laptop computer and the
recording was started. Successful operation of the device and adequate
quality of recordings were immediately verified by visual inspection of the
ECG and phonocardiogram on a 10-s snapshot recording (Fig 1). The
quality of the ECG was considered sufficient if the baseline was stable; P,
QRS and T waves were clearly discernible; and the ECG tracing was not
disturbed by excessive motion artefacts. Once proper device function was
verified, the wireless connection was discontinued and the device
continued recording to its internal data memory.
The recordings were conducted in a standardised way, starting between
17:00 and 20:00 and ending between 05:00 and 08:00 the following day,
aiming to obtain recordings of at least 10 h duration. Overnight recordings
were chosen to reduce the influence of environmental factors and
individual daytime activity patters, with the aim to improve data quality,
allow better standardisation of recordings and facilitate comparison of
results between horses. All recordings were taken in the horses’ familiar
environment and the owners were advised to leave the horses undisturbed
until recordings were finished. No other restrictions were imposed and
barn work continued as usual. After completion of recordings, the raw data
files were copied via USB connection from the Dx Patch device onto a
laptop computer.
In a subset of 10 randomly selected horses, recordings were repeated
every second day to obtain a total of three recordings per horse, allowing
assessment of the reproducibility of acoustic cardiography variables in this
group of horses.
Data processing and analyses
Copies of all data files were renamed using a coding system. Blinded data
processing and analyses were subsequently performed by Inovise Medical
Inc.c using proprietary data analysis software (CA 300). The software
algorithm relies on a sophisticated wavelet-based signal processing
technique to evaluate heart sound data in relation to the ECG data (Fig 1)
[16]. The diagnostic algorithm has been trained to set the sound fiducial
points based on large (human) datasets. The time–frequency analysis
allows separation of heart sounds from murmurs, external noise,
pulmonary sounds and artefacts. Each sound component has a very
specific time–frequency “fingerprint”, so that all four heart sounds can be
identified and timed. In contrast to auscultation and traditional
phonocardiography, the sound energy of the third and fourth heart sound
(S3 and S4) is quantified, so that S3 and S4 are recorded as continuous
rather than dichotomous variables. Sinus arrhythmia does not significantly
impact analyses, because all indices are calculated as an average of all
beats over 10 s. However, an isolated S4, such as in second-degree AV
block, is neither detected nor quantified by the analysis algorithm, because
it lacks association with a QRS-T complex. The algorithm also does not
analyse for S4 in the case of atrial arrhythmia with AV blocks, atrial
fibrillation or atrial flutter. Comparison of the filtered signals from dogs,
pigs, horses and other animals to those of humans does not show any
fundamental differences concerning their frequency content and the
placement of the relevant fiducial points (Inovise Medical Inc., personal
communication).
The analyses provided by Inovise Medical Inc. included a Holter ECG
report, a “cardiac findings” report and a 10-s “baseline snapshot” report.
Such “snapshots” are routinely recorded in people to obtain a point-of-care
set of variables for assessment of LV systolic and diastolic function without
the necessity of an ambulatory long-term recording [30]. Artefact periods
were detected based on an automated proprietary algorithm. Segments
were labelled as artefacts if the ECG signal did not allow consistent beat
detection or if the frequency domain of the sound signal had a low signal-
to-noise ratio. All labelled artefact periods were confirmed by a trained
technician and subsequently excluded from analyses.
Holter ECG analyses were performed on all complete recordings based
on the entire recording time available. The report included the duration of
analysed time, the duration of artefact-free time, and the number of
analysed beats; the minimum, maximum and average heart rate; and the
number and type of supraventricular and ventricular arrhythmias. The
rhythm diagnoses were confirmed and if necessary corrected by a trained
ECG technician. All detected rhythm events were additionally verified by an
equine clinician with expertise in rhythmology (CS).
Automated acoustic cardiography analysis was performed in all subjects
during a fixed time window from 22:00 to 05:00, resulting in a maximum
analysis period of 7 h for all horses. Artefact periods were excluded from
analyses. At least 4 h of ECG and phonocardiogram recordings were
required for successful acoustic cardiography analyses. The following
variables were generated and averaged over the entire analysed time
window and reported as “cardiac findings” (see Fig 1 and Supplementary
Item 1): Heart rate (HR), QRS duration (QRS), heart rate-corrected QT
interval (QTc), electromechanical activation time (EMAT), heart rate-
corrected electromechanical activation time (EMATc), left ventricular
systolic time (LVST) and the heart rate-corrected left ventricular systolic
time (LVSTc). Furthermore, the “cardiac findings” report contained the
percentage of 10-s segments contained in the analysis period with EMATc
≥15%; the strength (as a function of intensity and persistence) of the third
(S3) and fourth heart sound (S4) ≥5; and a systolic dysfunction index (SDI,
as a function of QRS duration, QT interval, EMATc, and S3) ≥5 and ≥7.5,
respectively. Note that in humans, S3 and S4 are considered to be present
if their power is ≥5 (on a scale of 0–10) [31] and EMATc ≥15%, SDI ≥5 and
SDI ≥7.5 were found to predict LV systolic dysfunction and poor prognosis
[20,23,30,32]. Hence, the respective cut-off values used by the analysis
software were those established by the manufacturer and approved by the
FDA to guide diagnosis in human patients. It was not possible to adjust
these cut-offs for the purpose of this study.
A 10-s “baseline snapshot” analysis was created from data recorded
during the first 2 min after start of the recording. The variables included in
a)
b)
c)
Fig 2: a) Audicor! Dx Patch device. b) Audicor! Dx Patch device with
attachment. c) Illustration of the experimental set-up on the horses.
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the snapshot analysis were the following: HR, EMAT, EMATc, LVST, LVSTc,
S3, S4 and SDI (see Supplementary Item 1 for a glossary of all variables).
Statistical analysis
Data analysis and statistics were performed using commercially available
software (Microsoft Excel for Mac 2011, v14.6.4d; GraphPad PRISM for Mac
OS X, v7.0be).
Summary statistics (mean, s.d., median) and reference intervals of each
variable were calculated using dedicated software (Reference Value
Advisor v2.1f). Due to the large sample size, nonparametric reference
intervals were calculated. The 90% confidence intervals (CIs) of the limits of
the reference intervals were determined using a bootstrap method. The
relationship of obtained variables to age, height and body weight was
assessed using linear regression analyses. For non-normally distributed
variables, linear regression analyses were conducted on log-transformed
data. Validity of the linear model was assessed by graphical display of the
data and assessment of normal probability plots of the residuals.
Bonferroni correction was performed to adjust for the family-wise error
rate after conducting eight individual linear regression analyses in the
“snapshot” statistics (adjusted level of significance, P = 0.05/8 = 0.0063)
and 12 individual linear regression analyses in the “cardiac findings”
statistics (adjusted level of significance, P = 0.05/12 = 0.0042).
The horses were then divided into five age groups (0–5, 6–10, 11–15,
16–20, 21–27 years) and groups were compared using one-way ANOVA
followed by Tukey post hoc test (for normally distributed variables) or
Kruskal–Wallis test followed by Dunn’s post hoc test (for non-normally
distributed variables). To assess the data for differences in sex, only mares
and geldings were considered, while stallions were excluded because of
insufficient group size (n = 3) for statistical analyses. Sex groups were
compared using unpaired t test (for normally distributed variables) or
Mann–Whitney test (for non-normally distributed variables). Normal
distribution and equal variance of the data in the different groups were
assessed by graphical display of the data and inspection of distribution and
normal probability plots of the residuals.
The test reproducibility was quantified based on the three repeated
measurements obtained in each of the 10 randomly selected horses.
Reproducibility was quantified by use of the within-subject variance for
repeated measurements (residual mean square) determined by a one-way
ANOVA with horses as the groups. The within-subject standard deviation
(sw) was calculated as the square root of the residual mean square.
Measurement variability and recording variability were reported in two
ways. First, for all normally distributed variables, the within-subject CV
expressed as a per cent value was calculated as CV = sw/mean 9 100.
The CV primarily served to compare the degree of variability between
different variables and across different studies. However, the interpretation
of the CV is difficult and not standardised and its clinical applicability is
limited [33]. Therefore, in addition to the CV, the absolute value below
which the difference between two measurements will lie with 95%
probability was estimated for all variables following the British Standards
Institution (BSI) recommendations as follows: 1.96 9 √2 9 sw = 2.77 9 sw
[34]. This measure of variability considers uncertainty of the point
estimates and uncertainty of prediction associated with repeated
measurements [33]. When applied clinically, the magnitude of change
observed in a variable over time can be put in relation to the BSI value, to
judge whether the change might be simply due to measurement error and
physiologic variability (observed change ≤BSI value) or whether the change
might represent a true change over time (observed change >BSI value).
Results
Acoustic cardiography “snapshot” and ambulatory ECG recordings could
be obtained in all 123 horses included in the study and all horses were in
sinus rhythm. However, in five recordings, the device had turned off
inadvertently during data collection, and in two horses, it detached from
the surcingle, resulting in insufficient data for Holter analyses and “cardiac
findings” reports in those seven cases (5.7% of horses). In additional 19
cases, the surcingle dislodged from its designated position during the
recording, and the ECG signal was temporarily lost due to a loosened
contact of the dry electrode to the skin. Nonetheless, all those 19
recordings contained enough data to perform all intended analyses. Hence,
data from 116 horses were included in the Holter and “cardiac findings”
statistics.
For complete Holter ECG analyses (n = 116), the mean duration of
analysed time was 12:22 h (s.d. 0:51 h, range 10:14–14:36 h) and the
mean artefact-free time was 10:21 h (s.d. 2:44 h, range 1:08–14:03 h),
including a mean of 22,813 beats (s.d. 6070, range 3042–35,392 beats).
The average heart rate was 37 beats/min (mean; s.d. 4 beats/min) and the
minimum and maximum heart rates were 30 beats/min (s.d. 4 beats/min)
and 91 beats/min (s.d. 24 beats/min), respectively. During manual
verification of the automated rhythm diagnoses, 1260 complexes that were
labelled as atrial premature complexes (APC) and seven complexes that
were labelled as ventricular premature complexes (VPC) were reclassified
as normal beats; five beats that were labelled as APCs were reclassified as
VPCs; and one beat that was labelled as normal beat was reclassified as
APC. Fifty-two of 116 horses (44.8%) had between one and 27 APCs,
corresponding to a minimum of 0.0032% and a maximum of 0.18% of all
analysed beats. Five of 116 horses (4.3%) had between one and four VPCs,
corresponding to a minimum of 0.0034% and a maximum of 0.021% of all
analysed beats.
Summary statistics of the “cardiac findings”, their reference intervals and
their relationship to age, body weight and height are shown in Table 1. The
S3 (≥5) and S4 (≥5) were significantly but weakly related to age; EMATc,
LVST and EMATc (≥15%) were significantly related to body weight; and S3
(≥5) was significantly related to height. However, R2 was low for all
relationships. After Bonferroni correction to adjust for the family-wise error
rate, only the percentage detected 10-s segments in which the power of
the third heart sound was ≥5 (S3 [≥5]) remained significantly but weakly
related to age, while none of the other variables was correlated with age,
body weight or height. Comparisons of variables between age groups are
summarised in Fig 3 and Supplementary Item 2. Only S3 (≥5) was
significantly different between the age groups 0–5 and 16–20 years
(P = 0.027). Comparisons between sex groups revealed that QRS duration
was significantly shorter in mares (114 ! 10 ms, 95–130 ms [mean ! s.d.,
5–95th percentile]) compared to geldings (120 ! 21 ms, 106–133 ms;
P = 0.037, difference between means 6 ms, 95% CI of difference of means
0.4–13 ms), while none of the other variables was significantly different
between groups.
Summary statistics of “snapshot” analyses and their relationship to age,
body weight and height are shown in Table 2. Heart rate and LVST were
significantly related to age; S3 strength was significantly related to body
weight; and none of the “snapshot” variables was significantly related to
height. After Bonferroni correction to adjust for the family-wise error rate,
only HRbas was significantly but weakly related to age. Comparisons
between sex groups revealed that SDIbas was significantly lower in mares
(2.3 ! 1.0, 1.1–4.4) compared to geldings (2.8 ! 1.0, 1.4–5.0; P = 0.024,
difference between means 0.5, 95% CI of difference of means 0.06–0.8),
while none of the other variables was significantly different between
groups.
The reproducibility of “cardiac findings” and “snapshot” variables is
summarised in Table 3. Overall, variability in normally distributed “cardiac
findings” variables, quantified using the between-day CV, was considerably
lower than variability in the baseline “snapshot” variables. The coefficient of
variation was not calculated for non-normally distributed “cardiac findings”
variables including EMATc (≥15%), S3 (≥5), S4 (≥5), SDI (≥5) and SDI (≥7.5).
However, based on their BSI value, relative to their median and range,
these variables showed moderate to high variability.
Discussion
This is the first study describing the feasibility, reliability and reference
intervals of acoustic cardiography variables in horses. The ambulatory data
included single-lead ECG recordings that were used for conventional Holter
analyses. Furthermore, the technology allowed continuous recording of
haemodynamic systolic and diastolic data by combined, simultaneous
analysis of ECG and heart sounds throughout the recording period.
Ambulatory Holter ECG recordings have previously been used in horses
for heart rate and rhythm analyses over prolonged periods of time [5].
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However, none of the diagnostic methods currently used in clinical practice
can continuously record and analyse haemodynamic data characterising
and quantifying systolic and diastolic ventricular function over several
hours or even days. Therefore, while there is still room for improvement
and development with respect to device attachment and consistent
recording quality, acoustic cardiography has potential to provide added
value over conventional diagnostic tools such as echocardiography,
systemic blood pressure measurements or cardiac catheterisation.
Similar to other Holter ECG systems currently used in horses, automated
Holter ECG analysis by Audicor! was prone to artefacts and classification
error in respect to detection of APCs and VPCs, respectively. Therefore, full
disclosure over-reading of the automated analysis results by a trained
veterinary specialist is mandatory. The corrected Holter ECG analyses in
this study indicate that atrial premature complexes were common in
overnight recordings in this group of clinically healthy horses (occurring in
44.8% of all horses), whereas ventricular premature complexes were rare
(occurring in 4.3% of all horses). While this finding is not unexpected and
corresponds to findings reported by other authors [35–38], this is the
largest original study describing Holter ECG analyses in resting,
undisturbed horses. The analyses further showed that in these apparently
healthy horses, up to 0.18% of analysed beats were of atrial ectopic origin
and up to 0.021% of beats were of ventricular ectopic origin.
This study served to establish reference intervals for Audicor! acoustic
cardiography variables in large-breed horses. The results indicate that
when accounting for the family-wise statistical error, none of the measured
variables, including QRS, QTc, EMAT, EMATc, LVST and LVSTc, is related to
age, weight, height (Tables 1 and 2) and that all of them are reproducible,
with a CV of well below 10%, when measured and averaged in an overnight
recording (Table 3). Day-to-day variability is considerably higher for EMAT,
EMATc and LVSTc when derived from a 10-s baseline “snapshot”
recording. The Audicor! variables EMAT and LVST correspond (but are not
identical [21]) to the echocardiographic variables pre-ejection period (PEP)
and left ventricular ejection time (LVET). Day-to-day variability in PEP (CV
6.7 and 11.9%) and LVET (CV 6.9 and 4.5%) measured by tissue Doppler
imaging (TDI) in horses has been recently reported in the literature [39,40]
The respective CVs suggest that reproducibility of systolic time intervals is
higher for overnight Audicor! recordings compared to single-point TDI
measurements. Whether Audicor!-derived EMAT and LVST will therefore
be more sensitive to detect changes in LV systolic function compared to
echocardiography will have to be investigated in future studies.
The normal intervals found for heart rate, QRS duration and QTc interval
correspond well with those previously reported in the literature for healthy
horses of similar body weight [38]. The QRS duration and consequently the
SDIbas, which is calculated as a function of QRS duration, QT interval,
EMATc and S3, were significantly lower in mares compared to geldings.
Because of the low number of stallions in the study group, no inference
could be made regarding stallions or male horses in general. However, the
literature suggests that the QRS duration in stallions exceeds those of
mares by 5–10 ms [41], a difference that is similar in magnitude to the
mean difference in QRS duration of 6 ms found between mares and
geldings in this study. This also corresponds to studies in people, showing
that the QRS duration is significantly longer in men than in women [42,43].
With reference to the QT interval, it is important to note that the Bazett
formula is only one of many methods for rate-correction of the QT interval,
but it is neither considered the only nor the best one. In horses, it has
recently been postulated that QT shortening during exercise follows a
piecewise linear model [44]. However, since no modifications to the
Audicor! correction methods could be made for the purpose of this study,
Bazett-corrected QTc was reported.
Direct statistical comparison of the Audicor! variables EMAT and LVST
with the corresponding echocardiographic variables PEP and LVET,
respectively, was beyond the scope of this study. However, one would
expect that EMAT, lasting from onset of the electrocardiographic Q wave
to the start of isovolumic contraction (which is timely related to the first
heart sound, S1), is shorter than PEP, which lasts from onset of Q to the
start of ventricular ejection (corresponding to aortic valve opening and
onset of aortic blood flow). Conversely, LVST, lasting from the start of
isovolumic contraction (S1) to the end of ejection (which is timely related to
the second heart sound, S2) should be longer than LVET, which lasts from
begin to end of ventricular ejection (aortic valve opening to closure)
[21,27]. This is concurrent with recent studies using tissue Doppler imaging
for assessment of left ventricular function in horses, in which reported PEP
(127 ! 25.3 ms; 121 ! 14.1 ms) was longer than EMAT and LVET
(404 ! 18.9 ms; 421 ! 24.7 ms) was shorter than LVST reported in this
TABLE 1: Summary statistics and reference intervals of “cardiac findings” variables obtained in clinically healthy horses (n = 116).
Summary statistics Linear regression
Variable Unit Mean s.d. Median
Lower limit of
reference
interval (90% CI)
Upper limit of reference
interval (90% CI)
Age Body weight Height
R2 P R2 P R2 P
HR beats/min 36 3.7 36 28 (25–30) 43 (41–44) 0.021 0.12 <0.01 0.89 <0.01 0.80
QRS ms 116 9.4 116 95 (92–99) 132 (131–140) <0.01 0.56 0.032 0.055 <0.01 0.77
QTc ms 385 25.2 385 338 (319–344) 439 (426–455) <0.01 0.47 <0.01 0.87 0.011 0.25
EMAT ms 108 15.4 107 78 (61–86) 142 (134–153) 0.020 0.13 <0.01 0.67 <0.01 0.38
EMATc % 7.5 2.5 7 4.0 (4.0–5.0) 14.1 (13.0–16.0) 0.011 0.26 0.039 0.034 <0.01 0.90
LVST ms 468 60.4 483 278 (238–305) 533 (524–538) <0.01 0.96 0.047 0.020 0.023 0.11
LVSTc % 29.3 2.4 29 23.9 (21.0–25.0) 34.0 (33.0–34.0) <0.01 0.97 <0.01 0.44 0.020 0.13
EMATc (≥15%) % n/a n/a 3.5 0.0 (0.0–0.2) 49.3 (37.5–73.4) 0.033 0.054 0.043 0.028 <0.01 0.45
S3 (≥5) % n/a n/a 1.9 0.2 (0.1–0.4) 19.7 (13.5–23.4) 0.072 0.0036* 0.011 0.27 0.045 0.023
S4 (≥5) % n/a n/a 1.7 0.1 (0.0–0.2) 13.0 (9.6–22.6) 0.038 0.039 <0.01 0.98 <0.01 0.57
SDI (≥5) % n/a n/a 0.6 0.0 (0.0–0.0) 13.5 (9.7–25.6) 0.017 0.20 0.010 0.32 0.026 0.11
SDI (≥7.5) % n/a n/a 0.1 0.0 (0.0–0.0) 5.0 (3.1–10.3) 0.026 0.18 0.023 0.21 0.023 0.20
For a complete glossary of variables, see Supplementary Item 1. n/a, not applicable, because variable is not normally distributed (LR performed after log
transformation).
HR, heart rate; QRS, QRS duration; QTc, rate-corrected QT interval; EMAT, electromechanical activation time; EMATc, rate-corrected electromechanical
activation time; LVST, left ventricular systolic time; LVSTc, rate-corrected left ventricular systolic time; EMATc (≥15%), per cent detected 10 s segments in
which the electromechanical activation time is greater than or equal the threshold value of 15%; S3 (≥5), per cent detected 10 s segments in which the
power of the third heart sound is greater than or equal the threshold value of 5; S4 (≥5), per cent detected 10 s segments in which the power of the
fourth heart sound is greater than or equal the threshold value of 5; SDI (≥5), per cent detected 10 s segments in which the systolic dysfunction index is
greater than or equal the threshold value of 5; SDI (≥7.5), per cent detected 10 s segments in which the systolic dysfunction index is greater than or
equal the threshold value of 7.5.
*Significant after Bonferroni correction (P<0.0042).
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study, respectively [28,39]. Both EMAT and LVST are shorter in people
compared to horses [21,27,31], which can be explained by different body
mass and cardiac size. Conversely, EMATc and LVSTc are higher in people
compared to horses, likely related to the markedly lower resting heart rate
in horses, leading to disproportionally longer diastolic time and RR interval
in relation to the systolic time intervals. Linear correction of EMAT and
LVST to RR is indirectly supported by findings in people, indicating that
both LV PEP and LVET are linearly related to increases in heart rate [45]. To
our knowledge, this has not been investigated in horses. These differences
suggest that EMATc (≥15%) [20,23,30,32] may not be valid to predict LV
systolic dysfunction in horses and that a different cut-off value will have to
be established. However, these comparisons overall suggest that the
concept of acoustic cardiography to continuously measure systolic time
intervals is applicable to horses and provides plausible and physiologically
meaningful results. Their clinical value, however, remains to be
determined.
Concerning the strength of diastolic heart sounds, the data of this study
indicate that both S3 and S4 are detected in virtually all horses at some
time point during the acoustic cardiography recordings. In people, S3 and
S4 are considered to be present if their power is ≥5 [31]. Applying this
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Fig 3: Comparison of heart rate, EMATc (≥15%), S3 (≥5) and S4 (≥5) between age groups. EMATc (≥15%), per cent detected 10-s segments in which the electromechanical
activation time is equal to or exceeding the threshold value of 15%; S3 (≥5), per cent detected 10-s segments in which the power of the third heart sound is equal to or
exceeding the threshold value of 5; S4 (≥5), per cent detected 10-s segments in which the power of the fourth heart sound is equal to or exceeding the threshold value
of 5.
TABLE 2: Summary statistics and reference intervals of baseline “snapshot” variables obtained in clinically healthy horses (n = 123).
Summary statistics Linear regression
Variable Unit Mean s.d. Median
Lower limit of
reference
interval (90% CI)
Upper limit of
reference
interval (90% CI)
Age Body weight Height
R2 P value R2 P value R2 P value
HRbas beats/min 38 6.1 38 28 (25–30) 48 (46–81) 0.089 <0.001* <0.01 0.70 <0.01 0.76
EMATbas ms 98 21.4 94 62 (61–66) 153 (137–168) <0.01 0.57 0.017 0.15 <0.01 0.50
EMATcbas % 5.9 1.8 6 3.0 (3.0–4.0) 9.9 (9.0–16.0) 0.021 0.11 <0.01 0.32 <0.01 0.46
LVSTbas ms 492 43.6 495 362 (310–426) 563 (559–592) 0.039 0.029 <0.01 0.8 <0.01 0.98
LVSTcbas % 31.2 4.0 32.0 22.0 (20.0–25.0) 38.9 (38.0–41.0) 0.021 0.11 <0.01 0.68 <0.01 0.76
S3bas 3.7 1.0 3.5 2.3 (2.0–2.5) 6.3 (5.4–8.7) <0.01 0.31 0.034 0.047 <0.01 0.31
S4bas 3.1 1.1 3.1 1.3 (0.5–1.4) 5.9 (4.7–7.0) <0.01 0.91 <0.01 0.85 <0.01 0.47
SDIbas 2.5 1.0 2.4 1.1 (0.4–1.2) 4.8 (4.5–5.4) 0.017 0.18 <0.01 0.64 <0.01 0.49
For a complete glossary of variables, see Supplementary Item 1. HR, heart rate; EMAT, electromechanical activation time; EMATc, rate-corrected
electromechanical activation time; LVST, left ventricular systolic time; LVSTc, rate-corrected left ventricular systolic time; S3, power of the third heart
sound; S4, power of the fourth heart sound; SDI, systolic dysfunction index.
*Significant after Bonferroni correction (P<0.0063).
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same cut-off, S3 was present in 0.2–19.7% (2.5–97.5th percentile) and S4
was present in 0.1–13.0% of all 10-s segments analysed during the
overnight recordings.
Prevalence of S3 is high in people less than 40 years of age and
decreases thereafter, whereas prevalence of S4 increases with advanced
age [27,31,46]. Similarly, in this study, S3 more often had a higher intensity
and persistence in younger horses compared to older ones. Conversely,
the fourth heart sound S4 tended to be less pronounced in young horses,
but the differences were not statistically significant. These findings are
consistent with earlier studies on diastolic heart sounds in horses [29,47–
49]. Typically, S3 is described as a low-intensity, low-pitched early-diastolic
sound that is not heard consistently in all horses but is considered a
normal finding in most instances [29,47,48]. Occurrence of S3 is reported
to be as high as 50% [47,48] and clinical experience suggests that S3 is
most often heard in fit athletic animals and is a less common finding in
older horses and ponies [50]. The fourth heart sound is heard in late
diastole immediately prior to S1. It should be detected in nearly all horses
in sinus rhythm and is particularly pronounced in horses with slow heart
rate and long PQ interval [5,49,50]. In agreement with this study, the
literature suggests that auscultatory characteristics of S4 appeared similar
in animals of different age [49].
Intensity and persistence of diastolic heart sounds in horses can change
with development of cardiac disease. Atrial fibrillation will inevitably result
in an absence of S4, while the intensity of S3 can be increased in horses
with severe mitral insufficiency, atrial fibrillation and heart failure [5,29,51].
In people with heart failure, increased intensity and persistence of S3 are
associated with lower ejection fraction, larger left atrial and left ventricular
dimensions, LV diastolic dysfunction and restrictive filling patterns
[23,30,52,53]. The diagnostic and prognostic values of the intensity and
persistence of S3 in horses with cardiac disease are not well established.
Furthermore, the description of the presence of diastolic heart sounds in
horses, when assessed by auscultation, varies between clinicians and is
significantly affected by training and level of experience [11]. Therefore,
application of acoustic cardiography could be useful in horses with severe
heart disease to objectify presence and intensity of diastolic heart sounds
and to establish their clinical and prognostic value. This said, Audicor!
variables characterising S3 and S4 in horses were affected by a high day-
to-day variability. While it is not possible to distinguish to which extent the
day-to-day variability is caused by physiological haemodynamic variation
and by measurement error inherent to the technology (including variation
in positioning of the microphone relative to the points of maximum
intensity of S3 and S4), these findings suggest that clinically relevant
alterations in S3 and S4 would need to be sufficiently large to be reliably
detected in individual horses over time. Furthermore, it is unclear whether
the human cut-offs of S3 (≥5) and S4 (≥5) can be used in horses to define
the presence of diastolic heart sounds. The same is also true for the SDI, a
combined index of QRS duration, QT interval, EMATc, and S3. While useful
to predict LV systolic dysfunction and poor prognosis in people with heart
disease [20,23,30,32], day-to-day variability in SDI is high in horses. The
magnitude of change seen with LV systolic dysfunction in horses and
appropriate cut-off values for SDI for diagnostic and prognostic purposes
are unknown. This will have to be investigated in future studies including
horses with cardiac disease.
The 10-s baseline “snapshop” strip, which was derived from the first
minutes of each recording, can be regarded as a rapid point-of-care test.
Ideally, such a “snapshot” analysis would be sufficient to measure systolic
time intervals, quantify the intensity of diastolic heart sounds and assess
cardiovascular function in horses with cardiac disease in field settings,
avoiding the necessity of an ambulatory long-term recording. However,
reproducibility for EMATbas, EMATcbas, S3bas, S4bas and SDIbas was
considerably lower than those for “cardiac findings” variables. Horses have
a prominent resting vagal tone and a markedly lower resting heart rate
compared to people, resulting in fewer and sometimes varying heart beats
included in the “snapshot” analysis. Transient sympathetic stimulation
immediately after instrumentation and second-degree AV blocks may also
influence “snapshot” recordings to a varying degree. Hence, similar to
other point-of-care diagnostic methods (e.g. manually counting heart beats
for 10 s to calculate the heart rate in beats/min), physiologic
haemodynamic variability and environmental factors likely diminish
reproducibility of “snapshot” data. Potentially, reproducibility could be
increased by granting an accommodation period after instrumentation and
by analysing longer recordings of 20 s or more. However, technical
restrictions in the Audicor! system make it impossible to adjust the
“snapshot” time interval for use in horses so far. Therefore, the use of
standard “snapshot” recordings for trending of haemodynamics over
multiple days or comparing haemodynamics on different days has likely
limited clinical utility in individual horses, unless the changes to be
detected are sufficiently large.
The study has several limitations that should be mentioned. First, we
have to acknowledge that the Audicor! algorithms were established based
on human databases. While correlations of Audicor! measurements with
ECG, echocardiography and invasive haemodynamics have been well
established in people [32,54–58]; this was beyond the scope of this initial
study. However, the 2D and 3D graphical representation of the equine
phonocardiograms (Fig 1) and the reproducibility data suggest that the
time–frequency analysis allowed consistent detection of all four heart
sounds and sufficient definition of sound fiducial points. Also, as discussed
above, comparison of Audicor! variables with published data of ECG time
intervals and echocardiography-derived systolic time intervals in horses
TABLE 3: Reproducibility of “cardiac findings” and baseline
“snapshot” variables in 10 healthy horses.
Summary statistics
Between-day
variability
Variable Unit
Mean
[Median]
s.d. [2.5–97.5th
percentile] CV (%) BSI
“Cardiac findings” variables
HR beats/min 36 2.7 4.7 4.6
QRS ms 119 6.1 0.7 2.2
QTc ms 376 17.4 4.3 44.4
EMAT ms 105 9.3 3 8.6
EMATc % 7.1 1.5 7.7 1.5
LVST ms 473 32.1 2.5 33.4
LVSTc % 28.9 1.1 2.8 2.2
EMATc (≥15%) % [3.5] [0.1–27.4] n/a 7.8
S3 (≥5) % [1.7] [0.4–19.7] n/a 3.7
S4 (≥5) % [1.4] [0.4–8.9] n/a 3
SDI (≥5) % [0.8] [0–7.2] n/a 3.5
SDI (≥7.5) % [0.3] [0–1.6] n/a 1
Baseline “snapshot” variables
HRbas beats/min 37 3.5 9.6 10
EMATbas ms 92 24.2 15.7 40.0
EMATcbas % 5.2 1.4 16.4 2.4
LVSTbas ms 502 26.9 3.5 48.2
LVSTcbas % 31.1 2.8 9 7.7
S3bas 3.5 0.7 19.2 1.9
S4bas 2.9 1.2 43.1 3.5
SDIbas 2.5 1.3 34.8 2.4
For a complete glossary of variables, see Supplementary Item 1. CV,
coefficient of variation; BSI, British standards institution; HR, heart rate;
QRS, QRS duration; QTc, rate-corrected QT interval; EMAT, electro-
mechanical activation time; EMATc, rate-corrected electromechanical
activation time; LVST, left ventricular systolic time; LVSTc, rate-corrected
left ventricular systolic time; EMATc (≥15%), per cent detected 10 s
segments in which the electromechanical activation time is greater than or
equal the threshold value of 15%; S3 (≥5), per cent detected 10 s segments
in which the power of the third heart sound is greater than or equal the
threshold value of 5; S4 (≥5), per cent detected 10 s segments in which the
power of the fourth heart sound is greater than or equal the threshold
value of 5; SDI (≥5), per cent detected 10 s segments in which the systolic
dysfunction index is greater than or equal the threshold value of 5; SDI
(≥7.5), per cent detected 10 s segments in which the systolic dysfunction
index is greater than or equal the threshold value of 7.5; S3, power
(intensity and persistence) of the third heart sound, range between 0 and
10; S4, power (intensity and persistence) of the third heart sound, range
between 0 and 10; SDI, systolic dysfunction index.
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showed that Audicor! measurements were within sensible, physiologically
meaningful ranges. Future investigations including gold standard
measurements such as multilead ECG recordings, echocardiography and
intracardiac pressure measurements will have to confirm this contention
and will serve to better characterise the accuracy of the Audicor! method
for use in horses.
Second, the study group was deemed clinically healthy based on history
and physical examination, but without further examination such as
echocardiography, laboratory examination or standardised exercise
testing. Therefore, there is a small possibility to have included horses with
some subclinical pathologies that had not become apparent during
physical examination. Further studies including healthy horses and horses
with cardiac disease, both verified using advanced diagnostic methods, will
be required to confirm the current results and to establish appropriate cut-
off values to distinguish healthy from diseased patients.
Another limitation was the loss of data because of technical difficulties
with the device and the surcingle attachment. Data quality of the ECG and
the phonocardiogram is largely influenced by motion artefacts and by
endogenous and exogenous noises. Therefore, while it is not possible to
restrain a horse for a prolonged period of time to reduce recording
artefacts in long-term recordings, improvement of the surcingle mounting
system will be required to ensure optimised data quality in future studies.
Even then, adjustment of the sensor position to account for the varying
point of maximum intensity of the heart sounds in individual horses will
hardly be possible. However, Audicor! measurements of time intervals do
not rely on absolute sound intensity but rather on an acceptable signal-to-
noise ratio. As the results of this study indicate, the signal conditioning and
detection models for the heart sounds were not markedly impacted by the
variation in the sensor location in relation to the point of maximum
intensity of the heart sounds. This can be explained by the fact that the
Audicor! method is very sensitive, so that even sound intensities that are
not audible by the human ear can be reliably detected, particularly for low
frequency heart sounds.
Finally, the Audicor! system only provides a single lead ECG in a base-
apex-like configuration. While basic Holter ECG analyses are feasible with
this setup, more advanced analyses of unusual or difficult-to-diagnose
rhythm disturbances will not be possible because of the lack of additional
ECG leads. Nonetheless, a single lead ECG recording is sufficient for
analysis of acoustic cardiography data.
Conclusion
In conclusion, acoustic cardiography using Audicor! technology is feasible
in horses. It is completely noninvasive and can easily be used in field
settings. It provides single-lead ECG recordings for conventional Holter
analyses including heart rate and basic rhythm diagnoses. Combination
with a phonocardiogram allows continuous measurement of systolic time
intervals and quantification of diastolic heart sounds over prolonged
periods of time. When applied to overnight recordings, the technology
provides a noninvasive method that has the potential to be used for
assessment and monitoring of cardiovascular function in horses. While
interpretation of ECG traces for comprehensive rhythm analyses need full
disclosure over-reading by a trained veterinary specialist, calculation of
acoustic cardiography variables is based on automated algorithms and
therefore independent of examiner input. This study provides proof of
concept for acoustic cardiography in horses and sets the stage for further
studies to establish the diagnostic and prognostic value of acoustic
cardiography in horses with heart disease.
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